NCT06497647 - New Treatment for Nocturnal Enuresis in Children | Biotech Hunter

Enrollment

450

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

November 30, 2024

Conditions

Nocturnal Enuresis in Children

Interventions

DRUG

Sulbutiamine

"sulbutiamine will be used by oral route 100 mg daily for 1 month and follow up will be done every 1 month till 3 months.~it will be used alone in group B and combined with imipramine in group C"

DRUG

Imipramine

"imipramine will be used by oral route 25 mg daily for 1 month and follow up will be done every 1 month till 3 months.~it will be used alone in group A and combined with sulbutiamine in group C"

Trial Locations (1)

Unknown

RECRUITING

Sohag Faculty of Medecine, Sohag

All Listed Sponsors

lead

Sohag University

OTHER